US4863737A
(en)
*
|
1985-05-01 |
1989-09-05 |
University Of Utah |
Compositions and methods of manufacture of compressed powder medicaments
|
US5855908A
(en)
*
|
1984-05-01 |
1999-01-05 |
University Of Utah Research Foundation |
Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
|
US4573995A
(en)
*
|
1984-10-09 |
1986-03-04 |
Alza Corporation |
Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
|
US4655767A
(en)
*
|
1984-10-29 |
1987-04-07 |
Dow Corning Corporation |
Transdermal drug delivery devices with amine-resistant silicone adhesives
|
US4751087A
(en)
*
|
1985-04-19 |
1988-06-14 |
Riker Laboratories, Inc. |
Transdermal nitroglycerin delivery system
|
US5122127A
(en)
*
|
1985-05-01 |
1992-06-16 |
University Of Utah |
Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
|
US5132114A
(en)
*
|
1985-05-01 |
1992-07-21 |
University Of Utah Research Foundation |
Compositions and methods of manufacture of compressed powder medicaments
|
US5288497A
(en)
*
|
1985-05-01 |
1994-02-22 |
The University Of Utah |
Compositions of oral dissolvable medicaments
|
US4671953A
(en)
*
|
1985-05-01 |
1987-06-09 |
University Of Utah Research Foundation |
Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
|
US4885173A
(en)
*
|
1985-05-01 |
1989-12-05 |
University Of Utah |
Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
|
US4645502A
(en)
*
|
1985-05-03 |
1987-02-24 |
Alza Corporation |
Transdermal delivery of highly ionized fat insoluble drugs
|
EP0223524B1
(fr)
*
|
1985-11-08 |
1991-10-23 |
Nitto Denko Corporation |
Utilisation des pansements adhésifs pour la peau et préparations percutanées
|
US4666441A
(en)
*
|
1985-12-17 |
1987-05-19 |
Ciba-Geigy Corporation |
Multicompartmentalized transdermal patches
|
ATE71287T1
(de)
*
|
1986-06-13 |
1992-01-15 |
Alza Corp |
Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
|
US5344656A
(en)
*
|
1986-09-12 |
1994-09-06 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US4908027A
(en)
*
|
1986-09-12 |
1990-03-13 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US4863970A
(en)
*
|
1986-11-14 |
1989-09-05 |
Theratech, Inc. |
Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
|
US5006342A
(en)
*
|
1986-12-22 |
1991-04-09 |
Cygnus Corporation |
Resilient transdermal drug delivery device
|
US4906463A
(en)
*
|
1986-12-22 |
1990-03-06 |
Cygnus Research Corporation |
Transdermal drug-delivery composition
|
AU607172B2
(en)
*
|
1986-12-22 |
1991-02-28 |
Cygnus, Inc. |
Diffusion matrix for transdermal drug administration
|
AU601528B2
(en)
*
|
1986-12-22 |
1990-09-13 |
Ortho-Mcneil Pharmaceutical, Inc. |
Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
|
US4822802A
(en)
*
|
1987-02-24 |
1989-04-18 |
Alza Corporation |
Method of fentanly administration for postoperative pain relief
|
US5071656A
(en)
*
|
1987-03-05 |
1991-12-10 |
Alza Corporation |
Delayed onset transdermal delivery device
|
US5080646A
(en)
*
|
1988-10-03 |
1992-01-14 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5186939A
(en)
*
|
1987-04-23 |
1993-02-16 |
Cygnus Therapeutic Systems |
Laminated composite for transdermal administration of fentanyl
|
US4981782A
(en)
*
|
1987-05-14 |
1991-01-01 |
Sri International |
Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
|
US4853227A
(en)
*
|
1987-10-23 |
1989-08-01 |
Ciba-Geigy Corporation |
Transdermal administration of a systemic active agent to a premature neonatal infant
|
US4781924A
(en)
|
1987-11-09 |
1988-11-01 |
Alza Corporation |
Transdermal drug delivery device
|
US4863738A
(en)
*
|
1987-11-23 |
1989-09-05 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monooleate
|
US5925372A
(en)
*
|
1987-12-16 |
1999-07-20 |
Novartis Corporation |
Mixed solvent mutually enhanced transdermal therapeutic system
|
US5064654A
(en)
*
|
1989-01-11 |
1991-11-12 |
Ciba-Geigy Corporation |
Mixed solvent mutually enhanced transdermal therapeutic system
|
US4915950A
(en)
*
|
1988-02-12 |
1990-04-10 |
Cygnus Research Corporation |
Printed transdermal drug delivery device
|
US5223261A
(en)
*
|
1988-02-26 |
1993-06-29 |
Riker Laboratories, Inc. |
Transdermal estradiol delivery system
|
US5004610A
(en)
*
|
1988-06-14 |
1991-04-02 |
Alza Corporation |
Subsaturated nicotine transdermal therapeutic system
|
US5169382A
(en)
*
|
1988-10-03 |
1992-12-08 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5236714A
(en)
*
|
1988-11-01 |
1993-08-17 |
Alza Corporation |
Abusable substance dosage form having reduced abuse potential
|
US4891377A
(en)
*
|
1988-12-02 |
1990-01-02 |
Board Of Regents Acting For And On Behalf Of University Of Michigan |
Transdermal delivery of the narcotic analgesics etorphine and analogs
|
US5241925A
(en)
*
|
1988-12-27 |
1993-09-07 |
Dermamed |
Apparatus and techniques for administering veterinary medicaments
|
US5332577A
(en)
*
|
1988-12-27 |
1994-07-26 |
Dermamed |
Transdermal administration to humans and animals
|
US5139023A
(en)
*
|
1989-06-02 |
1992-08-18 |
Theratech Inc. |
Apparatus and method for noninvasive blood glucose monitoring
|
US4956171A
(en)
*
|
1989-07-21 |
1990-09-11 |
Paco Pharmaceutical Services, Inc. |
Transdermal drug delivery using a dual permeation enhancer and method of performing the same
|
US5512292A
(en)
*
|
1990-10-29 |
1996-04-30 |
Alza Corporation |
Transdermal contraceptive formulations methods and devices
|
US5149538A
(en)
*
|
1991-06-14 |
1992-09-22 |
Warner-Lambert Company |
Misuse-resistive transdermal opioid dosage form
|
US5508039A
(en)
*
|
1991-10-18 |
1996-04-16 |
Alza Corporation |
Controlled transdermal administration of melatonin
|
US5268179A
(en)
*
|
1992-02-14 |
1993-12-07 |
Ciba-Geigy Corporation |
Ultrasonically sealed transdermal drug delivery systems
|
DE69326848T2
(de)
*
|
1992-05-13 |
2000-01-27 |
Alza Corp |
Oxybutynin zur transdermalen Verabreichung
|
US5900250A
(en)
*
|
1992-05-13 |
1999-05-04 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutnin
|
US5607691A
(en)
*
|
1992-06-12 |
1997-03-04 |
Affymax Technologies N.V. |
Compositions and methods for enhanced drug delivery
|
US5591767A
(en)
*
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
US5451407A
(en)
*
|
1993-06-21 |
1995-09-19 |
Alza Corporation |
Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
|
WO1995001167A2
(fr)
*
|
1993-06-25 |
1995-01-12 |
Alza Corporation |
Incorporation d'un amide poly-n-vinylique a un systeme transdermique
|
CA2167526A1
(fr)
*
|
1993-09-29 |
1995-04-06 |
Lina Tormen Taskovich |
Renforcateur de permeation a base de monoglyceride/lactate
|
US5635204A
(en)
*
|
1994-03-04 |
1997-06-03 |
Montefiore Medical Center |
Method for transdermal induction of anesthesia, analgesia or sedation
|
US7027859B1
(en)
*
|
1994-09-26 |
2006-04-11 |
Alza Corporation |
Electrotransport delivery device having improved safety and reduced abuse potential
|
JPH10509072A
(ja)
|
1994-11-17 |
1998-09-08 |
アルザ・コーポレーション |
電気的移送式作用剤投与を強化するための組成物と方法
|
US5843014A
(en)
*
|
1995-03-24 |
1998-12-01 |
Alza Corporation |
Display for an electrotransport delivery device
|
US5879322A
(en)
*
|
1995-03-24 |
1999-03-09 |
Alza Corporation |
Self-contained transdermal drug delivery device
|
US6881208B1
(en)
*
|
1995-06-05 |
2005-04-19 |
Joseph B. Phipps |
Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
|
ZA964320B
(en)
*
|
1995-06-05 |
1997-01-13 |
Alza Corp |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US6425892B2
(en)
|
1995-06-05 |
2002-07-30 |
Alza Corporation |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US6216033B1
(en)
|
1996-05-22 |
2001-04-10 |
Alza Corporation |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US6572879B1
(en)
*
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
US6245347B1
(en)
*
|
1995-07-28 |
2001-06-12 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
US5840327A
(en)
*
|
1995-08-21 |
1998-11-24 |
Alza Corporation |
Transdermal drug delivery device having enhanced adhesion
|
US5667799A
(en)
*
|
1995-10-30 |
1997-09-16 |
Caldwell; Larry J. |
Method for treating headache pain with topical local anesthetic compositions
|
US5730721A
(en)
*
|
1996-01-25 |
1998-03-24 |
Vesture Corporation |
Medical applicator and method
|
US6007837A
(en)
*
|
1996-07-03 |
1999-12-28 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
US5968547A
(en)
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
US6174545B1
(en)
|
1997-07-01 |
2001-01-16 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
US6918901B1
(en)
|
1997-12-10 |
2005-07-19 |
Felix Theeuwes |
Device and method for enhancing transdermal agent flux
|
WO1999029364A1
(fr)
*
|
1997-12-11 |
1999-06-17 |
Alza Corporation |
Dispositif renforçant le flux d'agents transdermiques
|
DK1037687T3
(da)
|
1997-12-11 |
2009-01-26 |
Alza Corp |
Anordning til at forbedre et middels transdermale strömning
|
EP1911488A3
(fr)
|
1997-12-11 |
2008-12-03 |
Alza Corporation |
Dispositif pour améliorer le flux d'agent transdermique
|
DK1037686T3
(da)
*
|
1997-12-11 |
2006-01-02 |
Alza Corp |
Apparat til forögelse af transdermal gennemströmning af midler
|
CN100388916C
(zh)
|
1997-12-22 |
2008-05-21 |
阿尔扎有限公司 |
用于控释药物传递装置的速率控制膜
|
US6103771A
(en)
*
|
1998-03-20 |
2000-08-15 |
Caldwell Galer Incorporated |
Method of treating neuroma pain
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
US6858018B1
(en)
|
1998-09-28 |
2005-02-22 |
Vyteris, Inc. |
Iontophoretic devices
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
JP4864204B2
(ja)
|
1998-12-18 |
2012-02-01 |
アルザ・コーポレーション |
透明な経皮的ニコチン送達デバイス
|
GB9828480D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Dermatech Limited |
Transdermal drug delivery system
|
US20070196490A1
(en)
*
|
1999-01-22 |
2007-08-23 |
Powderject Research Limited |
Method of enhancing needleless transdermal powered drug delivery
|
US6541021B1
(en)
*
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
US6835194B2
(en)
*
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
US6548569B1
(en)
*
|
1999-03-25 |
2003-04-15 |
Metabolix, Inc. |
Medical devices and applications of polyhydroxyalkanoate polymers
|
ES2244422T3
(es)
*
|
1999-04-01 |
2005-12-16 |
Alza Corporation |
Dispositivos para la administracion transdermica de farmacos que comprenden un deposito de poliuretano para farmacos.
|
EP1212046A2
(fr)
|
1999-08-30 |
2002-06-12 |
Tepha, Inc. |
Produits polymeres jetables dans les toilettes
|
KR20010036685A
(ko)
|
1999-10-11 |
2001-05-07 |
김윤 |
펜타닐을 함유하는 매트릭스형 경피투여제
|
ES2253278T3
(es)
|
1999-12-10 |
2006-06-01 |
Alza Corporation |
Dispositivo y procedimiento para mejorar la perforacion cutanea con microprotuberancias.
|
DK1255547T3
(da)
|
2000-02-08 |
2008-12-01 |
Euro Celtique Sa |
Kontrolleret-frigivelsessammensætninger indeholdende opioid-agonist og antagonist
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
CA2402865A1
(fr)
*
|
2000-03-10 |
2001-09-20 |
Durect Corporation |
Formulations opioides
|
US7179483B2
(en)
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
AU8174601A
(en)
*
|
2000-07-31 |
2002-02-13 |
Nycomed Danmark As |
Fentanyl composition for nasal administration
|
ES2410532T3
(es)
*
|
2000-09-19 |
2013-07-02 |
Henkel Ag & Co. Kgaa |
Adhesivo de acrilo útil en sistemas de administración transdérmica de fármacos
|
US20020119187A1
(en)
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
US20050208117A1
(en)
*
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
JP5354763B2
(ja)
*
|
2001-03-16 |
2013-11-27 |
アルザ・コーポレーシヨン |
フェンタニルを投与するための経皮的張り付け剤
|
EP1757280A1
(fr)
|
2001-03-16 |
2007-02-28 |
ALZA Corporation |
Timbre transdermique pour l'administration de sufentanyle
|
ATE404193T1
(de)
*
|
2001-06-05 |
2008-08-15 |
Ronald Aung-Din |
Topische migränetherapie
|
US8329734B2
(en)
|
2009-07-27 |
2012-12-11 |
Afgin Pharma Llc |
Topical therapy for migraine
|
DE10141651B4
(de)
*
|
2001-08-24 |
2007-02-15 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
NZ531789A
(en)
*
|
2001-08-17 |
2006-01-27 |
Lavipharm Lab Inc |
A medical device from which analgesic drugs are delivered from a drug reservoir controlled by plasticizers and adhesive matrix material
|
DE10141650C1
(de)
*
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
KR100844312B1
(ko)
*
|
2001-09-06 |
2008-07-07 |
노사케미컬(주) |
펜타닐 경피 투여 제제
|
AU2003221752A1
(en)
*
|
2002-04-23 |
2003-11-10 |
Alza Corporation |
Transdermal analgesic systems with reduced abuse potential
|
GB0210397D0
(en)
*
|
2002-05-07 |
2002-06-12 |
Ferring Bv |
Pharmaceutical formulations
|
DE10223835A1
(de)
|
2002-05-28 |
2003-12-11 |
Labtec Gmbh |
Pflaster, enthaltend Fentanylum
|
CA2487123C
(fr)
|
2002-05-28 |
2011-10-18 |
Labtec Gesellschaft Fuer Technologische Forschung Und Entwicklung Mbh |
Timbre contenant du fentanyl
|
US7041320B1
(en)
|
2002-05-31 |
2006-05-09 |
Biotek, Inc. |
High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
|
US7157102B1
(en)
|
2002-05-31 |
2007-01-02 |
Biotek, Inc. |
Multi-layered microcapsules and method of preparing same
|
AU2003251482A1
(en)
*
|
2002-06-10 |
2003-12-22 |
Euro-Celtique, S.A. |
Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
AU2003268376A1
(en)
*
|
2002-08-30 |
2004-11-26 |
Watson Pharmaceuticals, Inc. |
Transdermal delivery systems and methods
|
JP4758101B2
(ja)
*
|
2002-09-13 |
2011-08-24 |
久光製薬株式会社 |
貼付剤
|
EP2422775A3
(fr)
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Séquestration de sous-unité et compositions et procédés associés
|
TWI296531B
(en)
*
|
2002-10-18 |
2008-05-11 |
Hisamitsu Pharmaceutical Co |
Transdermal adhesive preparations for topical administration of fentanyl
|
WO2004039317A2
(fr)
*
|
2002-10-25 |
2004-05-13 |
Euro-Celtique S.A. |
Analogues et promedicaments de buprenorphine
|
US20040086551A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Miller Kenneth J. |
Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
|
US20040102476A1
(en)
*
|
2002-11-25 |
2004-05-27 |
Chan Tai Wah |
High concentration formulations of opioids and opioid derivatives
|
BRPI0407323A
(pt)
*
|
2003-02-07 |
2006-02-21 |
Lohmann Therapie Syst Lts |
sistema terapêutico transdermal apropriado para uso térmico para acelarar a permeação de substáncias ativas e uso do mesmo
|
US20060062812A1
(en)
*
|
2003-03-11 |
2006-03-23 |
Calvin Ross |
Novel compositions
|
US20040191301A1
(en)
*
|
2003-03-27 |
2004-09-30 |
Van Duren Albert Philip |
Transdermal device having a phase change material
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
US7834147B2
(en)
*
|
2003-04-28 |
2010-11-16 |
Childrens Hospital Medical Center |
Saposin C-DOPS: a novel anti-tumor agent
|
US8790689B2
(en)
|
2003-04-30 |
2014-07-29 |
Purdue Pharma L.P. |
Tamper resistant transdermal dosage form
|
MXPA05011703A
(es)
*
|
2003-04-30 |
2006-01-23 |
Purdue Pharma Lp |
Forma de dosis transdermica resistente a los retardadores que comprende un componente de agente activo y un componente de agente adverso en el sitio distal de la capa del agente activo.
|
JP2007525601A
(ja)
*
|
2003-05-08 |
2007-09-06 |
テファ, インコーポレイテッド |
ポリヒドロキシアルカノエート医療用織物および医療用繊維
|
JP5137286B2
(ja)
*
|
2003-06-10 |
2013-02-06 |
帝國製薬株式会社 |
フェンタニル含有口腔粘膜貼付剤
|
US20070065463A1
(en)
*
|
2003-06-20 |
2007-03-22 |
Ronald Aung-Din |
Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
|
EP1651273B1
(fr)
*
|
2003-07-08 |
2012-08-29 |
Tepha, Inc. |
Matrices poly-4-hydroxybutyrate pour une administration prolongee de medicaments
|
US8524272B2
(en)
*
|
2003-08-15 |
2013-09-03 |
Mylan Technologies, Inc. |
Transdermal patch incorporating active agent migration barrier layer
|
JP2007503221A
(ja)
*
|
2003-08-22 |
2007-02-22 |
テファ, インコーポレイテッド |
ポリヒドロキシアルカノエート神経再生デバイス
|
WO2005044243A2
(fr)
|
2003-10-30 |
2005-05-19 |
Alza Corporation |
Systemes analgesiques transdermiques reduisant les risques d'abus de consommation
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
US8535711B2
(en)
*
|
2004-01-23 |
2013-09-17 |
Teikoku Pharma Usa, Inc. |
Medication disposal system
|
US7867511B2
(en)
|
2004-01-23 |
2011-01-11 |
Travanti Pharma Inc. |
Abuse potential reduction in abusable substance dosage form
|
ATE426399T1
(de)
|
2004-02-23 |
2009-04-15 |
Euro Celtique Sa |
Missbrauchsichere transdermale abgabevorrichtung fur opioide, enthaltend opioidantagonist in form von mikrokugelchen
|
US20050255150A1
(en)
*
|
2004-04-26 |
2005-11-17 |
Cassel Douglas R |
Wound treatment patch for alleviating pain
|
WO2005123039A1
(fr)
|
2004-06-12 |
2005-12-29 |
Collegium Pharmaceutical, Inc. |
Formulations de prevention des abus
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
US7641825B2
(en)
*
|
2004-08-03 |
2010-01-05 |
Tepha, Inc. |
Method of making a polyhydroxyalkanoate filament
|
JP4745747B2
(ja)
*
|
2004-08-12 |
2011-08-10 |
日東電工株式会社 |
フェンタニル含有貼付製剤
|
JP4824963B2
(ja)
*
|
2004-08-12 |
2011-11-30 |
日東電工株式会社 |
貼付材及び貼付製剤
|
US8252319B2
(en)
*
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
ES2346895T3
(es)
*
|
2004-10-21 |
2010-10-21 |
Durect Corporation |
Sistemas de administracion transdermica.
|
ATE481088T1
(de)
*
|
2005-01-28 |
2010-10-15 |
Tepha Inc |
Embolisierung unter verwendung von poly-4- hydroxybutyrat-partikeln
|
TW200640526A
(en)
*
|
2005-02-24 |
2006-12-01 |
Alza Corp |
Transdermal electrotransport drug delivery systems with reduced abuse potential
|
US7309809B2
(en)
*
|
2005-02-26 |
2007-12-18 |
Xennovate Medical Llc |
Adhesive attachment and removal device
|
US20060223786A1
(en)
*
|
2005-04-01 |
2006-10-05 |
Smith David J |
Transdermal pain control method and device
|
US7288098B2
(en)
|
2005-04-14 |
2007-10-30 |
Ethicon Endo-Surgery, Inc. |
Force limiting mechanism for medical instrument
|
US7740641B2
(en)
|
2005-04-14 |
2010-06-22 |
Ethicon Endo-Surgery, Inc. |
Clip applier with migrational resistance features
|
US7261724B2
(en)
|
2005-04-14 |
2007-08-28 |
Ethicon Endo-Surgery, Inc. |
Surgical clip advancement mechanism
|
US8523882B2
(en)
|
2005-04-14 |
2013-09-03 |
Ethicon Endo-Surgery, Inc. |
Clip advancer mechanism with alignment features
|
US8038686B2
(en)
*
|
2005-04-14 |
2011-10-18 |
Ethicon Endo-Surgery, Inc. |
Clip applier configured to prevent clip fallout
|
US7686820B2
(en)
*
|
2005-04-14 |
2010-03-30 |
Ethicon Endo-Surgery, Inc. |
Surgical clip applier ratchet mechanism
|
US7297149B2
(en)
|
2005-04-14 |
2007-11-20 |
Ethicon Endo-Surgery, Inc. |
Surgical clip applier methods
|
DE602006016441D1
(de)
*
|
2005-05-13 |
2010-10-07 |
Alza Corp |
Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss
|
US20090143761A1
(en)
*
|
2005-06-03 |
2009-06-04 |
Transdermal Patents Company, Llc |
Agent delivery system and uses of same
|
WO2006133103A2
(fr)
*
|
2005-06-03 |
2006-12-14 |
Trans-Dermal Patents Company, Llc |
Reservoir pour l'administration d'agents
|
WO2007035941A2
(fr)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Systeme d'administration transdermique de galantamine
|
WO2007035940A2
(fr)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Systeme d'administration de norelgestromine par voie transdermique
|
EP2308480B1
(fr)
|
2005-09-23 |
2014-08-13 |
ALZA Corporation |
Formulation de polyacrylate hautement chargée en activateur pour des applications transdermiques
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
US7888422B2
(en)
|
2005-11-09 |
2011-02-15 |
Mylan Technologies Inc. |
Long-wearing removable pressure sensitive adhesive
|
EP1956985A2
(fr)
*
|
2005-11-23 |
2008-08-20 |
Universität Zürich |
Traitement d'une allergie par administration épicutanée d'un allergène
|
JP2009528990A
(ja)
*
|
2006-02-13 |
2009-08-13 |
アヴィバ ドラッグ デリバリー システムズ |
スフェンタニルを含む接着性調製物およびそれを用いる方法
|
US20070259930A1
(en)
*
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
DE102006019293A1
(de)
*
|
2006-04-21 |
2007-10-25 |
LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH |
Pflaster, enthaltend ein Fentanyl Analogum
|
US20070248657A1
(en)
*
|
2006-04-25 |
2007-10-25 |
Smith David J |
Multi-compartment transdermal pain control device
|
JP5437790B2
(ja)
|
2006-04-28 |
2014-03-12 |
チルドレンズ ホスピタル メディカル センター |
膜貫通薬物送達システムに適用するためのプロサポシン由来の融合タンパク質又はポリペプチドを含む組成物
|
CN102160865A
(zh)
|
2006-05-16 |
2011-08-24 |
诺普神经科学股份有限公司 |
R(+)和s(-)普拉克索的组合物以及使用该组合物的方法
|
US20070278289A1
(en)
*
|
2006-05-31 |
2007-12-06 |
Toshiba Tec Kabushiki Kaisha |
Payment adjusting apparatus and program therefor
|
ES2622576T3
(es)
|
2006-06-19 |
2017-07-06 |
Alpharma Pharmaceuticals Llc |
Composiciones farmacéuticas
|
US20080009782A1
(en)
*
|
2006-06-28 |
2008-01-10 |
Alza Corporation |
Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
|
US20080004671A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Alza Corporation |
Vagus nerve stimulation via orally delivered apparatus
|
US8647664B2
(en)
*
|
2006-07-14 |
2014-02-11 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhesive preparation
|
CA2665841C
(fr)
|
2006-10-09 |
2016-04-05 |
Charleston Laboratories, Inc. |
Compositions pharmaceutiques
|
DK2117521T3
(da)
*
|
2006-11-03 |
2012-09-03 |
Durect Corp |
Transdermale indgivelsessystemer omfattende bupivacain
|
US7943683B2
(en)
*
|
2006-12-01 |
2011-05-17 |
Tepha, Inc. |
Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
AU2008224844B2
(en)
*
|
2007-03-14 |
2012-08-09 |
Knopp Neurosciences, Inc. |
Synthesis of chirally purified substituted benzothiazole diamines
|
NZ597621A
(en)
|
2007-05-25 |
2013-06-28 |
Tolmar Therapeutics Inc |
Sustained delivery formulations of risperidone compounds
|
EP2197532A1
(fr)
|
2007-08-06 |
2010-06-23 |
Serenity Pharmaceuticals Corporation |
Procédés et dispositifs pour l'administration de médicament desmopressine
|
US9017301B2
(en)
*
|
2007-09-04 |
2015-04-28 |
Mylan Technologies, Inc. |
Transdermal drug delivery systems comprising a coated release liner
|
KR101583680B1
(ko)
*
|
2007-10-15 |
2016-01-08 |
알자 코퍼레이션 |
펜타닐의 1일-1회 교체 경피 투여
|
EP2235171A1
(fr)
*
|
2007-12-12 |
2010-10-06 |
Aarhus Universitet (University Of Aarhus) |
Structure cristalline d'une pompe à protons de la membrane plasmique
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
CA2905541C
(fr)
|
2008-01-09 |
2020-02-11 |
Charleston Laboratories, Inc. |
Compositions pharmaceutiques renfermant un antiemetique et un analgesique opioide
|
CN101925355B
(zh)
|
2008-01-28 |
2013-05-29 |
帝国制药株式会社 |
含芬太尼的外用贴剂
|
EP2111857A1
(fr)
*
|
2008-04-25 |
2009-10-28 |
Acino AG |
Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
|
US11963995B2
(en)
|
2008-05-21 |
2024-04-23 |
Ferring B.V. |
Methods comprising desmopressin
|
US20100286045A1
(en)
|
2008-05-21 |
2010-11-11 |
Bjarke Mirner Klein |
Methods comprising desmopressin
|
NO2296686T3
(fr)
*
|
2008-05-21 |
2014-07-12 |
|
|
EP2282728B1
(fr)
|
2008-05-22 |
2015-02-25 |
H. Lundbeck A/S |
Modulation des récepteurs du domaine vps10p.
|
DK2732823T3
(da)
|
2008-06-25 |
2019-09-16 |
H Lundbeck As |
Modulering af TrpV : Vps10p-domæne-receptorsystemet til behandlingen af smerte
|
JP2011526889A
(ja)
|
2008-06-30 |
2011-10-20 |
アフギン ファーマ,エルエルシー |
局所局部的神経作用療法
|
CN102186350A
(zh)
|
2008-08-19 |
2011-09-14 |
诺普神经科学股份有限公司 |
使用(r)-普拉克索的组合物与方法
|
WO2010028652A1
(fr)
|
2008-09-12 |
2010-03-18 |
Nanoko A/S |
Composition de colostrum
|
US20100221313A1
(en)
*
|
2008-12-01 |
2010-09-02 |
Innovative Pharmaceuticals, Llc |
Transdermal reservoir patch
|
EP2379593A2
(fr)
|
2008-12-19 |
2011-10-26 |
H. Lundbeck A/S |
Modulation de la famille de récepteurs à domaine vps10p pour le traitement de troubles mentaux et comportementaux
|
WO2010095537A1
(fr)
*
|
2009-02-18 |
2010-08-26 |
久光製薬株式会社 |
Préparation transdermique
|
CA2765876A1
(fr)
*
|
2009-06-19 |
2010-12-23 |
Knopp Neurosciences, Inc. |
Compositions et methodes pour traiter la sclerose laterale amyotrophique (als)
|
CA2767576C
(fr)
|
2009-07-08 |
2020-03-10 |
Charleston Laboratories Inc. |
Compositions pharmaceutiques refermant un antiemetique et un analgesiqueopioide
|
EP2295046B1
(fr)
|
2009-09-14 |
2012-12-19 |
Acino AG |
Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
|
DE102009048973A1
(de)
*
|
2009-10-09 |
2011-04-14 |
Beiersdorf Ag |
Transdermale therapeutische Systeme enthaltend 4-n-Butylresorcin
|
US8267945B2
(en)
|
2009-10-09 |
2012-09-18 |
Ethicon Endo-Surgery, Inc. |
Clip advancer with lockout mechanism
|
US8262679B2
(en)
|
2009-10-09 |
2012-09-11 |
Ethicon Endo-Surgery, Inc. |
Clip advancer
|
WO2011054359A2
(fr)
|
2009-11-06 |
2011-05-12 |
University Of Copenhagen |
Méthode de détection précoce du cancer
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
WO2011095174A1
(fr)
|
2010-02-08 |
2011-08-11 |
Aarhus Universitet |
Polypeptides et polynucléotides u20 des virus de l'herpès humain 6 et 7 pour une utilisation en tant que médicament ou diagnostic
|
WO2011107100A1
(fr)
|
2010-03-03 |
2011-09-09 |
Aarhus Universitet |
Procédés et compositions pour la régulation de herv4
|
DK2557924T3
(da)
|
2010-04-13 |
2019-09-23 |
Relmada Therapeutics Inc |
Dermale farmaceutiske sammensætninger af 1-methyl-2',6'-pipecoloxylidid og fremgangsmåde til deres anvendelse
|
US9586044B2
(en)
|
2010-04-28 |
2017-03-07 |
Kimberly-Clark Worldwide, Inc. |
Method for increasing the permeability of an epithelial barrier
|
RU2585159C2
(ru)
|
2010-04-28 |
2016-05-27 |
Кимберли-Кларк Ворлдвайд, Инк. |
Устройство доставки лекарственного средства, применяемого при ревматоидном артрите
|
MX2012012317A
(es)
|
2010-04-28 |
2012-11-21 |
Kimberly Clark Co |
Arreglo de microagujas moldeado por inyeccion y metodo para formar el arreglo de microagujas.
|
JP5860033B2
(ja)
|
2010-04-28 |
2016-02-16 |
キンバリー クラーク ワールドワイド インコーポレイテッド |
siRNA送達用の医療デバイス
|
WO2011157275A1
(fr)
|
2010-06-14 |
2011-12-22 |
H. Lundbeck A/S |
Modulation de l'interaction entre sorla et les récepteurs des ligands de la famille du gdnf
|
PH12015501410A1
(en)
|
2010-12-22 |
2015-09-07 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
EP2654733B1
(fr)
|
2010-12-23 |
2016-04-06 |
Purdue Pharma LP |
Formes pharmaceutiques solides à usage oral résistant à la contrefaçon
|
US9993444B2
(en)
|
2011-01-10 |
2018-06-12 |
Invion, Inc. |
Use of beta-adrenergic inverse agonists for smoking cessation
|
US8696637B2
(en)
|
2011-02-28 |
2014-04-15 |
Kimberly-Clark Worldwide |
Transdermal patch containing microneedles
|
US9731121B2
(en)
|
2011-03-31 |
2017-08-15 |
Incline Therapeutics, Inc. |
Switch validation circuit and method
|
US8428708B1
(en)
|
2012-05-21 |
2013-04-23 |
Incline Therapeutics, Inc. |
Self-test for analgesic product
|
US8428709B1
(en)
|
2012-06-11 |
2013-04-23 |
Incline Therapeutics, Inc. |
Current control for electrotransport drug delivery
|
US8781571B2
(en)
|
2011-03-31 |
2014-07-15 |
Incline Therapeutics, Inc. |
Switch validation circuit and method
|
US20140243765A1
(en)
|
2011-09-22 |
2014-08-28 |
Samyang Biopharmaceuticals Corporation |
Percutaneously absorbable preparation containing fentanyl and homologue thereof
|
RU2014110700A
(ru)
|
2011-09-30 |
2015-11-10 |
ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. |
Система утилизации трансдермальных пластырей
|
KR20140067042A
(ko)
|
2011-09-30 |
2014-06-03 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
일반 약물 처리 시스템
|
PL2768418T3
(pl)
|
2011-10-19 |
2017-12-29 |
Ethicon Endo-Surgery, Inc. |
Urządzenie dopasowujące do nakładacza zacisków do zastosowania z robotem chirurgicznym
|
MX343262B
(es)
|
2011-10-27 |
2016-10-28 |
Kimberly Clark Co |
Administración transdérmica de agentes bioactivos de alta viscosidad.
|
BR112014011758A2
(pt)
|
2011-11-15 |
2017-05-09 |
The Walter And Eliza Hall Inst Of Medical Res |
composição farmacêutica, proteína de fusão, polinucleotídeo, vetor, célula isolada, métodos para produzir uma proteína de fusão, para tratar ou previnir uma doença ou condição, para diagnosticar a suscetibilidade de um indivíduo a desenvolver uma doença ou condição, para determinar uma adequabilidade do indivíduo para ingressar em um experimento de classificação dedroga, e para identificar um agente, uso de uma combinação, e, combinação.
|
EP2599478A1
(fr)
*
|
2011-11-30 |
2013-06-05 |
Acino AG |
Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
|
US9512096B2
(en)
|
2011-12-22 |
2016-12-06 |
Knopp Biosciences, LLP |
Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
EP2812640B1
(fr)
|
2012-02-10 |
2018-08-08 |
Carrier Corporation |
Procédé de détection de perte de fluide frigorifique
|
EP3485880A1
(fr)
|
2012-04-17 |
2019-05-22 |
Purdue Pharma LP |
Systèmes et procédés pour le traitement d'une réponse pharmacodynamique indésirable induite par opioïdes
|
EP2846822A2
(fr)
|
2012-05-11 |
2015-03-18 |
Prorec Bio AB |
Méthode de diagnostic et de traitement de troubles associés à la prolactine
|
US9757432B2
(en)
|
2012-11-14 |
2017-09-12 |
Ohio State Innovation Foundation |
Materials and methods useful for treating glioblastorna
|
KR101840526B1
(ko)
|
2013-02-05 |
2018-03-20 |
퍼듀 퍼머 엘피 |
내변조성 제약 제제
|
US10729714B2
(en)
|
2013-02-11 |
2020-08-04 |
Glycanova As |
Basidiomycete-derived cream for treatment of skin diseases
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
EP2986278A1
(fr)
|
2013-03-11 |
2016-02-24 |
DURECT Corporation |
Composition injectable à libération contrôlée comprenant un véhicule liquide à haute viscosité
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US9682068B2
(en)
|
2013-05-20 |
2017-06-20 |
Mylan Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
US20160008294A1
(en)
|
2013-06-04 |
2016-01-14 |
Purdue Pharma L.P. |
Transdermal delivery system
|
LT3019167T
(lt)
|
2013-07-12 |
2021-03-25 |
Knopp Biosciences Llc |
Eozinofilų ir (arba) bazofilų padidintų kiekių gydymas
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
WO2015023786A1
(fr)
|
2013-08-13 |
2015-02-19 |
Knopp Biosciences Llc |
Compositions et méthodes de traitement de troubles des cellules plasmatiques et de troubles prolymphocytaires à cellules b
|
US9763918B2
(en)
|
2013-08-13 |
2017-09-19 |
Knopp Biosciences Llc |
Compositions and methods for treating chronic urticaria
|
US20160208016A1
(en)
|
2013-08-29 |
2016-07-21 |
University Of Copenhagen |
Anti-ADAM12 antibodies for the treatment of cancer
|
EP3180040B1
(fr)
|
2014-08-15 |
2020-05-13 |
Tepha, Inc. |
Sutures auto-rétentives de poly-4-hydroxybutyrate et de copolymères de celui-ci
|
US9849124B2
(en)
|
2014-10-17 |
2017-12-26 |
Purdue Pharma L.P. |
Systems and methods for treating an opioid-induced adverse pharmacodynamic response
|
CA2969429C
(fr)
|
2014-12-11 |
2020-10-27 |
Tepha, Inc. |
Procedes d'orientation de fil multifilament et de monofilaments de poly-4-hydroxybutyrate et de copolymeres de celui-ci
|
US10626521B2
(en)
|
2014-12-11 |
2020-04-21 |
Tepha, Inc. |
Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
|
WO2016100708A1
(fr)
|
2014-12-19 |
2016-06-23 |
3M Innovative Properties Company |
Dispositif d'administration transdermique de médicament, comprenant du fentanyl
|
WO2016112271A1
(fr)
|
2015-01-08 |
2016-07-14 |
The Johns Hopkins University |
Compositions et procédés d'accélération de la résolution d'une inflammation pulmonaire aiguë
|
US10383816B2
(en)
|
2015-03-02 |
2019-08-20 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with cannabinoid combination products
|
US20160256410A1
(en)
|
2015-03-02 |
2016-09-08 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy in mammals with cannabinoids
|
WO2017152130A1
(fr)
|
2016-03-04 |
2017-09-08 |
Charleston Laboratories, Inc. |
Compositions pharmaceutiques
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
US20180049994A1
(en)
|
2016-08-16 |
2018-02-22 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with caryophyllene
|
US10377114B2
(en)
|
2017-04-20 |
2019-08-13 |
Inep Europe Sarl |
Method for making a transdermal fentanyl patch with even drug crystal distribution
|
US11052054B2
(en)
|
2017-04-19 |
2021-07-06 |
Inep Europe Sarl |
Method for manufacturing a transdermal device
|
US10391065B2
(en)
|
2017-04-19 |
2019-08-27 |
Inep Europe Sarl |
Method for making a transdermal fentanyl patch with even drug crystal distribution
|
US11389844B2
(en)
|
2018-03-20 |
2022-07-19 |
Verde Environmental Technologies, Inc. |
Blister pack disposal system
|
JP6912122B2
(ja)
*
|
2019-02-28 |
2021-07-28 |
日本臓器製薬株式会社 |
経皮投与製剤
|